| T = 6 months | T = 12 months |
---|
WOMACa
| 75.8% (N = 178) | 80.2% (N = 177) |
KSS function scoreb
| 58.7% (N = 213) | 62.6% (N = 219) |
VAS painc
| 83.3% (N = 204) | 85.6% (N = 201) |
-
aSeveral criteria exist for estimating clinically important improvements in using the WOMAC. We used a pragmatically chosen cut-off point of at least 20 points improvement
-
bKSS scores have been categorized in >80 excellent; 70–79 good; 60–69 fair and <60 bad [36]. We defined a clinically relevant improvement as one category improvement
-
cWe used a difference of 20Â mm or more as clinically relevant improvement [34]
-
dWOMAC: 3.1% were excluded because of ceiling. KSS function score: 4.6% were excluded because of ceiling. VAS pain: 5.4% were excluded because of ceiling